Welcome to the
Hepatitis B Foundation
IL-23 Predicts PegIFN Response in Chronic HBV
Feb 23 - High baseline serum levels of interleukin (IL)-23 can help to identify hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients who are likely to respond to pegylated interferon (PegIFN) treatment, a Chinese study indicates. Read more.
TDF Monotherapy ‘Reasonable’ Option in Entecavir-Resistant HBV
Feb 23 - The efficacy of tenofovir disoproxil fumarate (TDF) monotherapy is comparable to that of TDF plus entecavir in chronic hepatitis B patients with genotypic resistance to entecavir, according to researchers from the Republic of Korea. Read more.
Antiviral Treatment Improves Survival in Sorafenib-Treated Hepatitis B Related Hepatocellular Carcinoma
Feb 23 - For sorafenib-treated patients with hepatitis B virus-related hepatocellular carcinoma, antiviral therapy with nucleoside analogues is associated with improved survival, according to a study published online in theJournal of Gastroenterology and Hepatology. Read more.
Government Panel Recommends FIVE CUPS of Coffee a Day to Ward Off Heart Disease, Liver Cancer and Parkinson's
Feb 23 – A panel of experts from the Dietary Guidelines Advisory Committee, which convenes every five years, did a detailed assessment of coffee for the first time, and suggests 3-5 cups of the caffeinated beverage may help keep the doctor away, along with reducing the risk of liver cancer. Read more.
Living With Hepatitis B
Feb 23 - Learning how to mange a hepatitis B diagnosis, and still live a full, active life, is a resource from the Open Education Consortium featuring the interactive learning guide for acute and chronic HBV infection from the Hepatitis B Foundation. Learn more.
Hepatitis B Foundation
Welcomes Two New Board Members
Jan 26 – The HBF is proud to announce that Craig Esterly, engineer and business owner, and Wayne Yetter, pharmaceutical industry executive, have joined its Board of Directors. Both bring broad and deep experience in the healthcare arena, and are joining the Foundation at a time when we are rapidly expanding and accelerating our pace of research into finding a cure for hepatitis B. Read more...
Implementing the Viral Hepatitis Action Plan: The Role of Community Leadership
Jan 19 – Hep B United’s strategic approach and implementation of the Viral Hepatitis Action Plan is described by Kate Moraras, Director, Hep B United, Hepatitis B Foundation and Isha Weerasinghe, Sr. Policy Analyst, AAPCHO. Read more.
Shop 'Til you Drop with AmazonSmile and Support the Hepatitis B Foundation
Do you shop online with Amazon? Make the Hepatitis B Foundation your charity of choice and shop using AmazonSmile – same great selection, prices, and services AND the AmazonSmile Foundation supports the HBF by donating 0.5% of eligible purchases. Learn more here.
Viral Hepatitis Issues Examined at 2014 American Public Health Association (APHA) Annual Meeting
Jan 5 – Hepatitis B and C were among the important public health issues examined at the recent APHA meeting with presentations by Chari Cohen and Kate Moraras of the Hepatitis B Foundation. Read more.
Page last modified February 23, 2015